Effect of 4 years of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali

Effect of 4 years of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali

Abstract Background More than 200 million people live in areas of highly seasonal malaria transmission where Seasonal Malaria Chemoprevention (SMC) with sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ) was recommended in 2012 by WHO. This strategy is now implemented widely and protected more than...

Full description

Bibliographic Details
Main Authors: Almahamoudou Mahamar, Djibrilla Issiaka, Ahamadou Youssouf, Sidi M. Niambele, Harouna M. Soumare, Oumar Attaher, Amadou Barry, David L. Narum, Patrick E. Duffy, Brian Greenwood, Michal Fried, Alassane Dicko
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Malaria Journal
Subjects:
Antibody to MSP-142
AMA1
CSP
Seasonal malaria chemoprevention
Seropositivity
Online Access:https://doi.org/10.1186/s12936-020-03542-9

Internet

https://doi.org/10.1186/s12936-020-03542-9

Similar Items